SCHEMBL9716803

SCHEMBL9716803

CCCC(O)N(CC(C)C)CC(C)C

nearest known ligand 0.35

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.35
CA12 O43570 3/20 0.31
CA1 P00915 3/20 0.31
CA2 P00918 3/20 0.31
CA9 Q16790 3/20 0.31
LMNA P02545 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3915391 0.79 TSHR (0.40) TSHRCA12CA1CA2CA9
SCHEMBL181776 0.76 FDPS (0.35) TSHRLMNA
SCHEMBL975582 0.74 FDPS (0.41) TSHRCA12CA1CA2CA9
Hydrochloric Acid SCHEMBL31452970 0.74 FDPS (0.33) TSHRLMNA
Isopropyl Alcohol SCHEMBL2245070 0.72 TSHR (0.45) TSHRCA1LMNA
SCHEMBL29220683 0.70 TSHR (0.39) TSHRCA1LMNA
SCHEMBL5052430 0.70 TSHR (0.35) TSHRLMNA
SCHEMBL976818 0.70 MMP1 (0.35) CA12CA1CA2CA9LMNA
SCHEMBL3462020 0.70 OPRM1 (0.33)
SCHEMBL28056858 0.70 MAPT (0.39) TSHRLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107540565-A The preparation of N, N (two) alkyl amino alkyl (methyl) acrylamide or corresponding ester and its quaternary ammonium salt 赢创罗姆有限公司 2018-01-05 CN disclosed
US-5089529-A Antiarrhythmia agents NIPPON SHINYAKU CO., LTD. (JP) 1992-02-18 US disclosed
US-5089529-A Antiarrhythmia agents NIPPON SHINYAKU CO., LTD. (JP) 1992-02-18 US disclosed
US-4438235-A POLYETHERS, POLYESTERS, POLYURETHANES BASF WYANDOTTE CORPORATION (US) 1984-03-20 US disclosed
EP-0009154-B1 COMPLEXES OF 9-HYDROXYALKYL-PURINES, PROCESSES FOR PREPARING THEM AND THERAPEUTICAL COMPOSITIONS CONTAINING THE COMPLEXES AS ACTIVE INGREDIENTS Newport Pharmaceuticals International, Inc. (US) 1982-12-08 EP disclosed
EP-0009155-B1 9-HYDROXYALKYL-PURINES, PROCESSES FOR PREPARING THEM AND THERAPEUTICAL COMPOSITION CONTAINING THE 9-HYDROXYALKYL-PURINES AS ACTIVE INGREDIENTS Newport Pharmaceuticals International, Inc. (US) 1982-11-17 EP disclosed
US-4221910-A IMMUNOPOTENTIATORS, VIRICIDES, ANTILEUKEMIA AGENTS NEWPORT PHARMACEUTICALS INTERNATIONAL, INC. (US) 1980-09-09 US disclosed
US-4221909-A P-Acetamidobenzoic acid salts of 9-(hydroxyalkyl) purines SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) 1980-09-09 US disclosed
US-4221794-A Method of imparting immunomodulating and antiviral activity NEWPORT PHARMACEUTICALS INTERNATIONAL, INC. (US) 1980-09-09 US disclosed
EP-0009155-A1 9-Hydroxyalkyl-purines, processes for preparing them and therapeutical composition containing the 9-hydroxyalkyl-purines as active ingredients Newport Pharmaceuticals International, Inc. (US) 1980-04-02 EP disclosed
EP-0009154-A1 Complexes of 9-hydroxyalkyl-purines, processes for preparing them and therapeutical compositions containing the complexes as active ingredients Newport Pharmaceuticals International, Inc. (US) 1980-04-02 EP disclosed